These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 14206918)

  • 21. DIHYDROXYBUSULFAN (NSC-39069) IN CHRONIC MYELOCYTIC LEUKEMIA AND MISCELLANEOUS MALIGNANT NEOPLASMS.
    LOEB V
    Cancer Chemother Rep; 1964 Nov; 42():39-43. PubMed ID: 14226129
    [No Abstract]   [Full Text] [Related]  

  • 22. COMBINATION OF METHYLGLYOXAL BIS(GUANYLHYDRAZONE) (NSC-32946)AND 6-MERCAPTOPURINE (NSC-755) IN ACUTE GRANULOCYTIC LEUKEMIA.
    BAIRON M; JACQUILLAT C; WEIL M; BERNARD J
    Cancer Chemother Rep; 1965 Apr; 45():69-73. PubMed ID: 14328052
    [No Abstract]   [Full Text] [Related]  

  • 23. [EXPERIENCE WITH ETHYLENEIMINES].
    GERICKE D
    Neoplasma; 1964; 11():329-34. PubMed ID: 14200019
    [No Abstract]   [Full Text] [Related]  

  • 24. [MODERN TREATMENT OF LEUKEMIA].
    MOESCHLIN S
    Schweiz Med Wochenschr; 1965 Feb; 95():268-74 CONCL. PubMed ID: 14256573
    [No Abstract]   [Full Text] [Related]  

  • 25. [STIMULATION OF NEUTROPHILIA BY A POLYSACCHARIDE EXTRACT OF "VISCUM ALBUM". ITS THERAPEUTIC USE IN NEUTROPENIA].
    MATHE G; SCHNEIDER M; AMIEL JL; CATTAN A; SCHWARZENBERG L; BERNO M
    Rev Fr Etud Clin Biol; 1963 Dec; 8():1017-20. PubMed ID: 14102503
    [No Abstract]   [Full Text] [Related]  

  • 26. [STEROID DIABETES AND DISEASES OF THE HEMATOPOIETIC SYSTEM].
    KOTLAREK-HAUS S; HALAWA B; ORZECHOWSKA K
    Pol Tyg Lek; 1963 Nov; 18():1720-4. PubMed ID: 14121568
    [No Abstract]   [Full Text] [Related]  

  • 27. TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH CHLORAMBUCIL (NSC-3088) AND CYCLOPHOSPHAMIDE (NSC-26271).
    KAUNG DT; WHITTINGTON RM; PATNO ME
    Cancer Chemother Rep; 1964 Jul; 39():41-5. PubMed ID: 14201274
    [No Abstract]   [Full Text] [Related]  

  • 28. THE FEASIBILITY OF USING RANDOMIZATION SCHEMES EARLY IN THE CLINICAL TRIALS OF NEW CHEMOTHERAPEUTIC AGENTS: HYDROXYUREA (NSC-32065).
    CARBONE PP; KRANT MJ; MILLER SP; HALL TC; SHNIDER BI; COLSKY J; HORTON J; HOSLEY H; MILLER JM; FREI E
    Clin Pharmacol Ther; 1965; 6():17-24. PubMed ID: 14253279
    [No Abstract]   [Full Text] [Related]  

  • 29. PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: UROLOGIC AND GYNECOLOGIC NEOPLASMS.
    HOWE CD; SAMUELS ML
    Cancer Chemother Rep; 1964 Aug; 40():47-8. PubMed ID: 14206917
    [No Abstract]   [Full Text] [Related]  

  • 30. PHASE II STUDY OF A-8103 (NSC-25154) IN ACUTE LEUKEMIA IN ADULTS.
    HEWLETT JS; BATTLE JD; BISHOP RC; FOWLER WM; SCHWARTZ SO; HAGEN PS; LOUIS J
    Cancer Chemother Rep; 1964 Nov; 42():25-8. PubMed ID: 14226126
    [No Abstract]   [Full Text] [Related]  

  • 31. STUDY OF SERUM B12 AND FOLATE IN PATIENTS TREATED WITH HYDROXYUREA (NSC-32065).
    THURMAN WG; WATKINS WL
    Cancer Chemother Rep; 1964 Aug; 40():23-5. PubMed ID: 14206909
    [No Abstract]   [Full Text] [Related]  

  • 32. METHYLGLYOXAL BIS(GUANYLHYDRAZONE), NSC-32946, 1 IN THE TREATMENT OF ACUTE MYELOBLASTIC AND MONOBLASTIC LEUKEMIA IN ADULTS.
    SHAW RK; CREGER WP
    Cancer Chemother Rep; 1964 Mar; 36():63-71. PubMed ID: 14152278
    [No Abstract]   [Full Text] [Related]  

  • 33. MEGALOBLASTIC ERYTHROPOIESIS INDUCED BY HYDROXYUREA (NSC-32065).
    DE BERGSAGEL DE; FRENKEL EP; ALFREY CP; THURMAN WG
    Cancer Chemother Rep; 1964 Aug; 40():15-7. PubMed ID: 14206906
    [No Abstract]   [Full Text] [Related]  

  • 34. EXTREME HYPERURICEMIA ASSOCIATED WITH PREDNISONE THERAPY FOR ACUTE LYMPHOBLASTIC LEUKEMIA.
    ALPERIN JB; LEVIN WC
    Tex State J Med; 1964 Dec; 60():1001-4. PubMed ID: 14226966
    [No Abstract]   [Full Text] [Related]  

  • 35. [A NEW ANTIBIOTIC WITH CYTOSTATIC PROPERTIES: RUBIDOMYCIN].
    DUBOST M; GANTER P; MARAL R; NINET L; PINNERT S; PREUDHOMME J; WERNER GH
    C R Hebd Seances Acad Sci; 1963 Sep; 257():1813-5. PubMed ID: 14090569
    [No Abstract]   [Full Text] [Related]  

  • 36. RENAL ABNORMALITIES INDUCED BY HYDROXYUREA (NSC-32065).
    SAMUELS ML; HOWE CD
    Cancer Chemother Rep; 1964 Aug; 40():9-13. PubMed ID: 14206922
    [No Abstract]   [Full Text] [Related]  

  • 37. SURVIVAL RATES FOR LEUKEMIA IN VARIOUS COUNTRIES.
    LOCKWOOD K; STANCKE B; CLEMMESER J
    Natl Cancer Inst Monogr; 1964 Oct; 15():341-57. PubMed ID: 14248021
    [No Abstract]   [Full Text] [Related]  

  • 38. HYDROXYUREA: MECHANISM OF ACTION.
    FISHBEIN WN; CARBONE PP
    Science; 1963 Nov; 142(3595):1069-70. PubMed ID: 14068223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TRIETHYLENE MELAMINE IN THE CONTROL OF HODGKIN'S DISEASE AND THE LEUKEMIAS. IV. CLINICAL REPORTS, 1959-62.
    SAMPEY JR
    Am J Pharm Sci Support Public Health; 1963 Dec; 135():451-7. PubMed ID: 14101404
    [No Abstract]   [Full Text] [Related]  

  • 40. CLINICAL TRIALS OF HYDROXYUREA IN PATIENTS WITH CANCER AND LEUKEMIA.
    FISHBEIN WN; CARBONE PP; FREIREICH EJ; MISRA D; FREI E
    Clin Pharmacol Ther; 1964; 5():574-80. PubMed ID: 14209774
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.